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Genetic variability has a profound effect on the development of cardiac hypertrophy
in response to stress. Consequently, using a variety of inbred mouse strains with
known genetic profiles may be powerful models for studying the response to
cardiovascular stress. To explore this approach we looked at male C57BL/6J and 129/SvJ
mice. Hemodynamic analyses of left ventricular pressures (LVPs) indicated significant
differences in 129/SvJ and C57BL/6J mice that implied altered Ca2+ handling. Specifically,
129/SvJ mice demonstrated reduced rates of relaxation and insensitivity to dobutamine
(Db). We hypothesized that altered expression of genes controlling the influx and efflux
of Ca2+ from the sarcoplasmic reticulum (SR) was responsible and investigated the
expression of several genes involved in maintaining the intracellular and sarcoluminal
Ca2+ concentration using quantitative real-time PCR analyses (qRT-PCR). We observed
significant differences in baseline gene expression as well as different responses in
expression to isoproterenol (ISO) challenge. In untreated control animals, 129/SvJ mice
expressed 1.68× more ryanodine receptor 2(Ryr2) mRNA than C57BL/6J mice but only
0.37× as much calsequestrin 2 (Casq2). After treatment with ISO, sarco(endo)plasmic
reticulum Ca2+-ATPase(Serca2) expression was reduced nearly two-fold in 129/SvJ
while expression in C57BL/6J was stable. Interestingly, β(1) adrenergic receptor(Adrb1)
expression was lower in 129/SvJ compared to C57BL/6J at baseline and lower in both
strains after treatment. Metabolically, the brain isoform of creatine kinase (Ckb) was
up-regulated in response to ISO in C57BL/6J but not in 129/SvJ. These data suggest that
the two strains of mice regulate Ca2+ homeostasis via different mechanisms and may be
useful in developing personalized therapies in human patients.
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INTRODUCTION
Heart disease by any measure is a significant and ever increasing
health risk around the world. Cardiac pharmacogenetic studies
have revealed that although pharmaceutical efficacy is high for a
population, the range of individual response is great because of
genetic variability of individuals within the population (Roden
et al., 2011). This is particularly true for β-blockers and DNA
variants are suspected to modulate these differences (Brodde
et al., 2001; Port and Bristow, 2001). These types of variations
are one of the motivators for pursuing theranostic “personal-
ized medicine.” As individual variation impacts drug efficacy,
consideration should be given to how genetic variation extends
to the inherent development and progression of cardiac disease.
While advances in biology have focused heavily on the impact
of a specific gene on the outcome of a disease, taking a candi-
date gene approach has not been entirely productive. Frequently
at fault in animal models is the effect of the selected genetic
background, which can cause transgenes to produce different
and even contradictory results (Davie et al., 2007; Cook et al.,
2009). Yet moving to a whole genome approach is an extremely
difficult and exhaustive pursuit. To further compound the prob-
lem, transgenic mice are frequently created on one genetic back-
ground and then insufficiently backcrossed to another. As such,
there is a growing appreciation for variation in the physiology
between different strains. While genotypes are important, it is
the functional phenotype that is clinically observed that ulti-
mately matters. To investigate differences in cardiac function we
took a systems biology approach to analyze two common strains,
C57BL/6J mice and 129/SvJ mice during hypertrophic stress. Both
strains are commonly used to generate transgenic animals and
have previously observed significant morphological differences
(Grubb et al., 2009), such as the myocytes of 129/SvJ mice are
smaller, more tightly packed and have a decreased t-tubule density
(Shah et al., 2010). Additionally, 129/SvJ mice carry two ren-
nin genes (Ren 1d and Ren-2) which is likely reflected in the
observed elevated blood pressure (Wang et al., 2002; Lum et al.,
2004).
The focus of this work is the impact of background genetics
on cardiac function and the response to a hypertrophic stim-
ulus. We constrained our investigation further to the integral
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role of calcium handling via examination of gene expression
differences between two strains as a basis for a differential hyper-
trophic response. It is well-established that the production of
cytotoxicity via Ca2+ overload is a major stimulus to pathologic
hypertrophy in model systems. In the intact failing human heart,
it appears that β1-adrenergic signaling accounts for the major-
ity of pathologic hypertrophy in chronic heart failure (Port and
Bristow, 2001). This key role in heart failure made β-adrenergic
signaling prime candidates for comparison in gene expression
and in situ hemodynamics. Additionally, we took the next step
and investigated changes in the expression of several important
genes that regulate the sequestering of calcium in the sarcoplas-
mic reticulum (SR). The ryanodine receptor complex controls the
efflux of calcium from the SR upon the induction of calcium-
induced calcium release (CICR) (Kunitomo and Terentyev, 2011).
As such, we analyzed the expression of the ryanodine receptor
(Ryr2) and its associated proteins triadin (Trdn), junctate/junctin
(Asph). Calsequestrin 2 (Casq2) was included as it is the most
abundant protein located in the SR, acting both as a Ca2+
sink and coordinating release of Ca2+ through the Ryr2 chan-
nel (MacLennan and Wong, 1971; Periasamy and Huke, 2001).
In addition, we quantified the mRNA levels for sarcoplasmic
reticulum calcium ATPase (Serca2) and its associated protein
phospholamban (Pln) as these proteins actively pump intracel-
lular calcium back into the SR to facilitate muscle relaxation.
Finally, creatine kinase muscle and brain (Ckm and Ckb) iso-
forms play an important role in maintaining cellular energetics
that are necessary for pumping calcium and were also examined.
The expression of these genes was quantified under both con-
trol and isoproterenol (ISO) induced hypertrophic conditions in
conjunction with in situ hemodynamics. Our results show differ-
ences in the expression of genes between these two strains and
suggest different mechanisms by which the two strains main-
tain calcium equilibrium between the cytosol and SR. Utilizing
multiple murine strains as potential surrogates for modeling vari-
ation in the human genotype may ultimately be useful in the
development of pharmaceutical agents and scoring response to
therapeutic regimens.
METHODS
ANIMAL CARE
Male C57BL/6J and 129/SvJ mice (8–13 weeks old) were obtained
from Harlan Laboratories, housed in the University of Chicago
Animal Resource Center under standard housing and diet con-
ditions. Experimental protocols were approved by the University
of Chicago Institutional Animal Care and Use Committee
(IACUC).
PHARMACEUTICALS
Hypertrophy was induced by chronic ISO (Sigma) treatment
(S.C. 47mg/kg BW) via Alzet micro-osmotic pumps Model
1003D (Durect Corp) for 3 days. Pumps were removed 12 h prior
to conducting any experiments on the treated or sham animals.
Control animals received pumps with vehicle only and were oth-
erwise treated identically. Dobutamine (Db) (Sigma) was infused
at 8.3μg/min/gBW for 10min and 83μg/min/gBW for 1min in
both control and hypertrophic animals to increase contractility.
HEMODYNAMIC MEASUREMENTS
Mice were initially anesthetized with 2–3% isoflurane in 100%
oxygen in an induction box and then maintained under anes-
thesia through surgery with 1–2% isoflurane as needed deliv-
ered through a mask. A Millar microtip pressure catheter was
inserted through the right carotid and advanced to the left
ventricle (LV) of the mouse heart to record left ventricu-
lar pressure (LVP), the first derivative (±dP/dt), and heart
rate (HR).
RNA ANALYSIS
Hearts from C57BL/6J and 129/SvJ male mice were surgically
removed 6 h after the removal of the pumps. The apex was
excised for RNA isolation using Trizol reagent (Invitrogen). RNA
was checked for purity via UV spectroscopy and integrity via
agarose gel analysis. Samples with a degraded 28S band were
excluded from further analyses. RNA was diluted to 25 ng/ul
for qRT-PCR experiments. Genes of interest were PCR cloned
using TOPO-TA cloning kit (Invitrogen) and subsequently used
as template for RNA runoffs. This template RNA was DNase
(Invitrogen) treated, ethanol precipitated, and diluted serially
to generate standard curves for qRT-PCR applications. Primers
for template and qRT PCR are listed in Table 1. qRT-PCR
experiments were conducted with 100 ng RNA in 25μl reac-
tions using SYBER Green 2× Reaction mix on a MyIQ single
color detection system (Bio-Rad). β-actin mRNA was quantified
and found to be statistically indistinguishable between the four
groups of animals. Data is reported as fold expression relative
to untreated C57BL/6J animals. Due to recurrent non-specific
amplification, primers for AdBR1 and AdBR2 were obtained
from SABiosciences (PPM05035A-200 and PPM04265B-200).
Results for AdBR1 and AdBR2 are reported as normalized
fold expression to β-actin as determined using IQ5 software
(Bio-rad).
STATISTICAL ANALYSIS
Data (mean ± SE) are presented as relative fold expression to
untreated C57BL/6J animals. Data was analyzed on SigmaStat
analysis software (Systat Software, Inc.) using the Two-Way
ANOVA test and the Holm–Sidak post-hoc pairwise procedure.
Significant changes between groups are indicated in the figures by
asterisks.
RESULTS
MORPHOLOGY
Animal body weights (Bw) were measured along with iso-
lated hearts (Hw) after removal of major vessels and auricular
appendages. The average control Hw/Bw was 4.26 ± 0.073mg/g
(n = 14) for C57BL/6J and 4.29 ± 0.021mg/g (n = 15) for
129/SvJ. ISO significantly induced cardiac hypertrophy in
C57BL/6J by 26% [Hw/Bw of 5.42 ± 0.09mg/g (n = 10)]
and significantly greater (32%) in 129/SvJ [5.69 ± 0.071mg/g
(n = 17)]. Results and significance are illustrated in Figure 1.
HEMODYNAMICS
Hemodynamic measurements and significance are presented in
Figure 2. In brief, at baseline both C57BL/6J and 129/SvJ strains
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Table 1 | Gene and associated qRT primers.
Gene Accession number qRT primers qRT primer Tm Template primers
Ryr2 NM_023868 CAGCATCTCGTTTCGCATTA
GGCTGTGTTCCACCTTCAAT
58.7 TGTGAATCATGTCAGCAGCA
CAATGCCAGCAAAGTCTTGA
Casq2 NM_009814 ATTTATGGATGAGCCCACG
GTCACTCTTCTCCGCAAGG
57.0 TACACAGCTGCAGGACCAAG
CAATGCCCACACATTTCAAG
Asph Consensus TGGGAGAAGAGGAGGGATTT
TGGCATCATCCACATCAAAG
61.0 TGGCAGTACTGGTAGCCACA
CCCTTCCCTCTATCCTCCTG
Trdn NM_029726 GATGATGGCAAAAGAGGACAA
CTTCTTTCTGGCCTTTGGTG
57.0 TCAGCCAGAAAATCCAGGAA
CAGCTGGCATCTCTTTGTCA
Serca2 NM_001110140 TGGGCAAAGTGTATCGACAG
GGTCAGGGACAGGGTCAGTA
58.7 TGGAGAACGCTCACACAAAG
CAGTGGGTTGTCATGAGTGG
Pln NM_001141927 CACTGTGACGATCACCGAAG
ATAGCCGAGCGAGTGAGGTA
55.0 CTCCCATAAACCTGGGAACA
AGGGGACAACCACTTCCTCT
Ckm NM_007710 GAGATTCTCACTCGCCTTCG
GCCCTTTTCCAGCTTCTTCT
58.7 ATGCCGTTCGGCAACACC
CTACTTCTGCGCGGGGAT
Ckb NM_021273 AAGTTCTCGGAGGTGCTCAA
CCGTTGCTCCATCTCAATG
55.0 GAGATCCTCGAGATGCCCTTCTCCAA
GAGATCGTCGACTCACTTCTGGGCCG
Actb NM_007393 GCTCTTTTCCAGCCTTCCTT
CTTCTGCATCCTGTCAGCAA
55.8 TGTTACCAACTGGGACGACA
AGGGAGACCAAAGCCTTCAT
FIGURE 1 | Isoproterenol induced hypertrophy in C57BL/6J and
129/SvJ mice. Heart weight/Body weight ratios were determined and are
reported here as mg/g. ∗∗P < 0.01; ∗∗∗P < 0.001.
functioned similarly although 129/SvJ demonstrated diminished
relaxation [C57BL/6J: ±dP/dt 9893 ± 519/11047 ± 254mmHg/s
(n = 7); 129/SvJ: ±dP/dt 8978 ± 446/7442 ± 609mmHg/s
(n = 7)]. Db stimulation had the expected increase in contractil-
ity in both strains although −dP/dt did not reach significance in
129/SvJ [C57BL/6J: ±dP/dt: 13253 ± 559/12232 ± 446 (n = 7);
129/SvJ ±dP/dt: 11355 ± 750/9346 ± 1009mmHg/s (n = 7)].
Hypertrophy reduced contractility and although C57BL/6J
mice did not demonstrate a significant decrease in +dP/dt,
FIGURE 2 | In situ hemodynamic analyses of 129/SvJ and C57BL/6J
mice. Differences in contractility (+dP/dt) and relaxation (−dP/dt) between
strains with and without ISO treatment are reported. Asterisks indicate
significance. ∗P < 0.05; ∗∗∗P < 0.001.
there was a dramatic decrease in −dP/dt [C57bl/6J: ±dP/dt
8496 ± 1116/6685 ± 837mmHg/s (n = 5)]. In contrast 129/SvJ
mice demonstrated a dramatic decrease in overall con-
tractility which was significantly more than C57BL/6J
[129/SvJ ±dP/dt: 5214 ± 64/5013 ± 51mmHg/s (n = 4)].
As expected neither C57BL/6J nor 129/SvJ hypertrophic mice
responded significantly to Db stimulation [C57BL/6J ± dP/dt:
8391 ± 967/6478 ± 725mmHg/s (n = 5)] 129/SvJ ± dP/dt:
5749 ± 229/5834 ± 263mmHg/s (n = 4).
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FIGURE 3 | Expression of genes in the ryanodine receptor complex is
different between 129/SvJ and C57bl/6J mice. Significant changes
between groups are indicated by bars. P -values are indicated starred
designation. ∗P < 0.05; ∗∗∗P < 0.001.
RYANODINE CHANNEL EXPRESSION
The expression of four genes (Ryr2, Casq2, Asph, and Trdn)
associated with the ryanodine channel was quantified resulting
in strain dependence. Ryanodine receptor expression was sig-
nificantly higher in 129/SvJ animals [1.68 ± 0.131 (n = 11)]
compared to C57BL/6J (1 ± 0.14, n = 11). In this complex
there was no significant impact of ISO induced hypertrophy on
gene expression but there was an opposite trend between the
two strains. The result was the statistical equivalence of post-
treatment Ryr2 expression 129/SvJ (1.37 ± 0.32, n = 11) and
C57bl/6J (1.30 ± 0.16, n = 9). Casq2 expression was significantly
impacted by strain and was dramatically lower in 129/SvJ animals
(0.367 ± 0.026, N = 11) relative to C57BL/6J (1 ± 0.199, N =
11). Hypertrophy had no significant impact on Casq2 expres-
sion in either strain (C57BL/6J 0.96 ± 0.161, n = 11; 129/SvJ:
0.276 ± 0.052, n = 11). Gene expression of neither triadin nor
junctate/junctin, both products of the aspartate β-hydroxylase
(ASPH), was altered significantly by either strain or treat-
ment (Triadin—C57BL/6J baseline: 1 ± 0.164; ISO: 1.35 ± 0.41;
129/SvJ baseline: 1.29 ± 0.25; ISO: 1.55 ± 0.37; β-hydroxylase
(ASPH)—C57BL/6J baseline: 1 ± 0.13, ISO: 1.30 + 0.18, and
129/SvJ baseline: 1.08 ± 0.09, ISO 0.87 ± 0.16). Data and signifi-
cance are summarized in Figure 3.
SARCOPLASMIC RETICULUM ATPase AND PHOSPHOLAMBAN
Expression of Serca2 was significantly different between strains
(C57BL/6J: 1.0 ± 0.18; 129/SvJ:1.62 ± 0.33) and was dramat-
ically decreased by hypertrophy in 129/SvJ (0.85 ± 0.25)
but not in C57BL/6J hearts (0.77 + 0.12). Pln expression
was not significantly different due to strain (C57BL/6J:1 ±
0.16;0.129/SvJ:1.19 ± 0.15) and ISO-induced hypertrophy did
not significantly impact expression in C57BL/6J (1.19 ± 0.18) or
129/SvJ (0.81 ± 0.17). Data and significance are summarized in
Figure 4.
FIGURE 4 | Expression of Serca2 and Pln differ in 129/SvJ and
C57BL/6J mice. The Serca2 pump is elevated in 129/SvJ mice relative
to C57BL/6J but is significantly down-regulated after ISO challenge. Pln
is also down-regulated in 129/SvJ mice after ISO treatment. Significant
changes are indicated by starred designation. ∗P < 0.05.
CREATINE KINASE ISOFORM EXPRESSION
The expression of both brain and muscle isoforms of Ckb
were assessed in cardiac tissues. Although there was a trend
for CKM to be expressed at a lower level in C57BL/6J
compared to 129/SvJ at baseline, it did not reach statisti-
cal significance (C57BL/6J: 1 ± 0.25; 129/SvJ:1.56 ± 0.37). ISO
treatment had no impact on C57BL/6J (C57BL/6Jiso: 1.07 ±
0.34), but there was a striking trend in 129/SvJ indicating
decreased expression although it did not reach statistical sig-
nificance (129/SvJiso: 0.83 ± 0.20). In contrast, CKB expres-
sion was elevated in iso-treated C57BL/6J animals (1.67 ± 0.28)
relative to baseline (C57BL/6J: 1 ± 0.15). There was no sig-
nificant difference in 129/SvJ control (0.86 ± 0.14) or treated
(1.12 ± 0.25) groups. Results and significance are summarized in
Figure 5.
BETA-ADRENERGIC RECEPTOR EXPRESSION
Relative fold expression of the β1 and β2 adrenergic receptors
was determined in all four groups of mice. Consistent with pre-
vious reports, Adbr1 was the predominant receptor expressed
in cardiac tissue (data not shown) (Brodde et al., 2001). Adbr1
expression was strain dependent being over 2-fold higher in con-
trol C57BL/6J (1 ± 0.134) compared to 129/SvJ (0.43 ± 0.05).
Treatment with ISO caused the down-regulation of Adbr1 in
both C57BL/6J (0.52 ± 0.11) and 129/SvJ (0.23 ± 0.04) mice by
approximately 2-fold. Adbr2 expression was not significantly dif-
ferent between any of the four groups. Data for relative expression
and significance are represented in Figure 6.
DISCUSSION
Recent studies have shown that different strains of mice present
characteristic variations in cardiac physiology (Shah et al., 2010).
For example, hearts of 129/SvJ and C57BL/6J mice differ not
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FIGURE 5 | Creatine kinase expression is elevated in the hearts of
129/SvJ mice. Quantities of CK isoform mRNA are indicated in each graph.
Expression of each isoform in 129/SvJ mice differs in the response to ISO
when compared to C57BL/6J mice. Significant changes are indicated by
starred designation. ∗P < 0.05.
FIGURE 6 | Adbr1 is down regulated in 129/SvJ mice. Expression of the
β1-Adrenergic receptor in 129/SvJ mice is reduced 2-fold relative to
C57BL/6J. Both strains showed 2-fold reductions in Adbr1 expression after
ISO challenge indicating an appropriate response to the β1 agonist.
Significant changes are indicated by starred designation. ∗P < 0.05.
only morphologically but also in Ca2+ homeostasis (Barrick
et al., 2007; Shah et al., 2010). Consistent with these reports,
our hemodynamic analyses indicate altered Ca2+ homeostasis
and a blunted response to β-adrenergic agonists in 129/SvJ ani-
mals may be the basis for a greater hypertrophic response. These
two strains also show different sensitivities and altered responses
depending on the type of cardiovascular challenge. For exam-
ple, C57BL/6J mice have been reported to be more sensitive to
aortic constriction than 129/SvJ mice (Barrick et al., 2007). In
our study, 129/SvJ mice demonstrated an increased sensitivity
to ISO-induced hypertrophy compared to C57BL/6J mice, by
developing significantly more mass (Figure 1).
A prodigious amount of energy is spent maintaining the cal-
cium gradient in the SR, in which intra-sarcolemmal concentra-
tions exceed cytoplasmic concentrations by 5000-fold (Barry and
Bridge, 1993). Conceptually, this gradient is modulated through
three mechanisms, passive retention by calcium binding proteins
in the SR, escape through the ryanodine receptor complex, and
active pumping of Ca2+ into the SR via SERCA. As such, it is
easy to envision that alterations in the capacity of any of the
mechanisms can be offset by concomitant changes in the other
two. The balance of these three mechanisms is likely to impact
the cardiac physiology of the organism. Consequently, we inves-
tigated the expression of proteins controlling Ca2+ flux from the
SR. Based on the idea that each strain differs mechanistically in
maintaining Ca2+ homeostasis, perhaps they are predisposed to
different cardiovascular outcomes following stress. For example,
based on their transcriptional profile, ISO-induced cardiac hyper-
trophy in C57BL/6J mice has been shown to resemble ischemic-
related human cardiac hypertrophy (Galindo et al., 2009) due to
alteration in several calcium homeostatic and handling related
genes.
Interestingly, we observed over 2-fold higher expression of
calsequestrin in the hearts of C57BL/6J animals. Calsequestrin has
long been considered to act as a calcium sink in the SR (Campbell
et al., 1983). Using adenoviral technology in adult rat cardiomy-
ocytes, Terentyev et al. demonstrated that the amount of CASQ2
expression correlated with both calcium storage in the SR as well
as the size and duration of calcium transients upon stimulation
(Terentyev et al., 2003). Similarly, transgenic mice over-expressing
Casq2 have elevated SR Ca2+ content (Jones et al., 1998). Based
on these data one would predict C57BL/6J mice to have elevated
CASQ2 protein and SR Ca2+ content compared to 129/SvJ mice.
This is, however, in contrast to published observations in which
129/SvJ mice had the highest SR Ca2+ content of four strains
assayed (Shah et al., 2010) indicating the importance of other
mechanisms of calcium sequestration. In fact, mice with ablated
CASQ2 were able to maintain normal SR calcium content albeit
with a 50% increase in SR volume (Knollmann et al., 2006). This
points to the need for further characterization of these genes
at the protein level including post-translational modifications as
expression does not always correlate with neither protein quantity
nor activity.
In addition to the role CASQ2 plays in binding calcium,
there is mounting evidence of a critical role in mediating the
response of ryanodine receptor to SR luminal calcium concen-
trations (Terentyev et al., 2008; Knollmann, 2009) where CASQ2
can act as a sensor by adopting a more compact configuration
when binding Ca (Cozens and Reithmeier, 1984). Interactions
with TRDN and JNC are also clearly involved as shown in CASQ2
knockout mice. These nulls presented a dramatic reduction in
both TRDN and JNC, most likely due to decreased protein sta-
bility and/or decreased protein synthesis, as expression of both
genes was unchanged (Knollmann et al., 2006). Similarly, higher
concentrations of CASQ2 would also impact not only the phys-
ical conformation of CASQ2 but its intermolecular interactions
with junctate, junctin, triadin as well as with other CASQ2
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molecules. In fact, over-expression of calsequestrin in FVB mice
led to increased Ca2+ storage capacity of the SR. However, these
Ca2+ ions are not available for release during contraction caus-
ing a depression in contractile function and ultimately cardiac
hypertrophy (Sato et al., 2003).
Given their significantly higher Casq2 levels, a similar behavior
would be expected of C57BL/6J mice when compared to 129/SvJ.
On the contrary, they exhibited amoremuted response to chronic
ISO stimulation. This could be explained by considering that in
addition to the high capacity binding loci with elevated Casq2,
lower Ryr2 expression was observed in C57BL/6J mice, result-
ing in a dramatically different ratio of Ryr2:Casq2 in C57BL/6J
vs. 129/SvJ. We believe that this may impact the efflux of Ca2+
from the SR by altering the interactions among the proteins in
the ryanodine complex. Based on the current data, there is insuf-
ficient information to determine the mechanism and whether
there is mediation through triadin and junctate. The physical
restraints of fewer points of efflux coupled with higher buffering
capacity suggest an environment overall better suited for cal-
cium retention. It is conceivable that passive calcium retention
is energetically favorable and may justify the ISO-induced attenu-
ated hypertrophic response in C57BL/6J mice since β-adrenergic
stimulation is reflected in greater calcium efflux through phos-
phorylation of both Ryr2 and Pln (Li et al., 2000; Shan et al.,
2010). Including both strains in future studies will provide use-
ful insights into further defining the roles of TRDN and JNC in
regulating luminal SR calcium concentration.
Although requiring further examination, the attrition of
129/SvJ mice was greater during the ISO treatment compared to
C57BL/6J. This may be related to catecholamine-induced poly-
morphic ventricular tachycardia (CPVT) in which adrenergic
stimulation can frequently cause lethal arrhythmias in mice with
CASQ2 loss of function alterations (Song et al., 2007; Terentyev
et al., 2008). Mutations associated with familial CPVT are fre-
quently found in the CASQ2 and RYR2 genes. We would propose
that fewer Ryr2 channels would reduce the likelihood of a spon-
taneous depolarization and explains why we do not observe
similar arrhythmias in C57BL/6J animals. We believe that similar
variations in the human population can exist and that find-
ing such populations will allow for better prevention of disease
and, ultimately, more effective therapeutic intervention when
necessary.
While we consider the luminal retention of Ca2+ by CASQ2
to be very important, other factors need to be considered. It is
our hypothesis that adaptations in 129/SvJ SR compensate for
reduced CASQ2 expression. Higher Serca2 levels in 129/SvJ mice
indicate that this strain relies more heavily on active translo-
cation of cytosolic calcium to the SR lumen. This burden may
create a chronic strain on cellular ATP pools in 129/SvJ mice.
This is reflected in the down-regulation of β-receptors we observe
in 129/SvJ mice. The higher flux of calcium upon β-adrenergic
stimulation would theoretically have a greater impact on 129/SvJ
mice by increasing the energetic demands of maintaining appro-
priate calcium concentration gradients. Chronic β-adrenergic
stimulation affects Serca2 activity by phosphorylating and disso-
ciating its inhibitor Pln. This likely explains the change of Serca2
with ISO treatment in 129/SvJ mice. Rat hearts show decreased
Pln (Linck et al., 1998) and higher Pln phosphorylation after
ISO (Bossuyt et al., 2005), both having the effect of increasing
Serca2 activity. This effect, however, is not found in most of
patients presenting heart failure. Rather, Serca2 expression has
been found to be greatly reduced in several cardiac conditions,
including hypertrophic cardiomyopathies. Therefore, one must
carefully choose the type of stress but equally carefully the genetic
background which more closely recapitulate the related human
condition.
Genetic variation is well-known to play a role in the patho-
physiology of human left ventricular hypertrophy and in cardiac
failure overall. Most studies have focused on identifying the role
of polymorphisms and genetic variants of single candidate genes,
with inconsistent result (Bleumink et al., 2004). β-adrenergic
receptor blockers can improve symptoms and mortality rates in
heart failure, although with significant interindividual variations
(Liggett, 2000). Polymorphisms have been linked with these vari-
ations; however, here we have demonstrated that cardiac failure
involves a complex system of genes and their reciprocal interac-
tions. We believe these results have multiple implications. They
can find clinical application in helping predict the risk for heart
failure and characterize individual sensitivities to drugs, therefore
driving personalized treatment.
Clinical studies have indicated different geometric patterns of
LV hypertrophy exist in patients during the development and
management of hypertension. Patients with concentric, eccentric
LV hypertrophy, and normal baseline geometry were identified
and appeared fairly stable without transition to dilatation over
the 5 years followed (Conrady et al., 2005). Consequently, it is
not known whether the remodeling observed represents different
temporal stages in the development of heart failure or whether
there is a genetic predisposition in some individuals. Further
exploration and comparison of inbred strain-specific responses
to hypertrophic stimuli could lead to better preclinical models for
partitioning LVH by LV geometry which could provide prognostic
value in stratifying patients based on cardiovascular risk.
Pharmacogenetics studies and investigations of cardiomy-
opathies must keep the strain effect into consideration and differ-
ent mice strains can and should be used. Because it is ultimately
too expensive to create transgenic animals on a large number
of genetic backgrounds, it becomes very important to choose
an appropriate one. Through proper selection of the correct
strains, their crossing and the F1 hybrids can help determine the
impact of a transgene on a divergent enough background to bet-
ter determine the effects of that gene in a whole environment
rather than in isolation. Further experiments including altering
the hypertrophic stress are predicted to result in different adapta-
tions (Galindo et al., 2009). Expanding the number of strains is
likely to shed further light on gene interactions not fully appreci-
ated and similar to what is found in the genetically larger human
population.
AUTHOR CONTRIBUTIONS
Steve B. Waters, Douglass M. Diak, Matthew Zuckermann, and
Brian B. Roman performed experiments. Steve B. Waters, Lara
Leoni, and Brian B. Roman drafted manuscript. Douglass M.
Diak and Steve B. Waters prepared figures. Douglass M. Diak,
Frontiers in Physiology | Genomic Physiology March 2013 | Volume 4 | Article 11 | 6
Waters et al. Genetic background influences iso-induced hypertrophy
Steve B. Waters, and Brian B. Roman analyzed data. Steve B.
Waters, Douglass M. Diak, Brian B. Roman interpreted results
of experiments. Steve B. Waters, Lara Leoni, Paul H. Goldspink,
and Brian B. Roman revised manuscript. Steve B. Waters, Lara
Leoni, and Brian B. Roman approved final version of manuscript.
Paul H. Goldspink and Brian B. Roman conception and design of
research.
ACKNOWLEDGMENTS
We would like to thank David Geenen for comments on the
manuscript during preparation.
GRANTS
This work was supported by NIH 5R01HL69961 to Brian B.
Roman.
REFERENCES
Barrick, C. J., Rojas, M., Schoonhoven,
R., Smyth, S. S., and Threadgill,
D. W. (2007). Cardiac response to
pressure overload in 129S1/SvImJ
and C57BL/6J mice: temporal- and
background-dependent develop-
ment of concentric left ventricular
hypertrophy. Am. J. Physiol. Heart
Circ. Physiol. 292, H2119–H2130.
Barry, W. H., and Bridge, J. H. (1993).
Intracellular calcium homeostasis in
cardiac myocytes. Circulation 87,
1806–1815.
Bleumink, G. S., Schut, A. F. C.,
Sturkenboom, M. C. J. M., Deckers,
J.W., VanDuijn, C. M., and Stricker,
B. H. C. (2004). Genetic polymor-
phisms and heart failure. Genet.
Med. 6, 465–474.
Bossuyt, J., Ai, X., Moorman, J. R.,
Pogwizd, S. M., and Bers, D. M.
(2005). Expression and phosphory-
lation of the Na-pump regulatory
subunit phospholemman in heart
failure. Circ. Res. 97, 558–565.
Brodde, O. E., Bruck, H., Leineweber,
K., and Seyfarth, T. (2001).
Presence, distribution and physio-
logical function of adrenergic and
muscarinic receptor subtypes in the
human heart. Basic Res. Cardiol. 96,
528–538.
Campbell, K. P., MacLennan, D. H.,
Jorgensen, A. O., and Mintzer, M.
C. (1983). Purification and char-
acterization of calsequestrin from
canine cardiac sarcoplasmic reticu-
lum and identification of the 53,000
dalton glycoprotein. J. Biol. Chem.
258, 1197–1204.
Conrady, A. O., Rudomanov, O. G.,
Zaharov, D. V., Iakovleva, O. I.,
Ovchinnicova, O. A., Vahrameeva,
N. V., et al. (2005). Prospective
study of the changes in left ventric-
ular mass and geometry patterns in
hypertensive patients During 5 years
of follow-up. Circ. J. 69, 1374–1379.
Cook, S. A., Clerk, A., and Sugden, P.
H. (2009). Are transgenic mice the
‘alkahest’ to understanding myocar-
dial hypertrophy and failure? J. Mol.
Cell. Cardiol. 46, 118–129.
Cozens, B., and Reithmeier, R. A.
(1984). Size and shape of rabbit
skeletal muscle calsequestrin. J. Biol.
Chem. 259, 6248–6252.
Davie, S. A., Maglione, J. E., Manner,
C. K., Young, D., Cardiff, R. D.,
MacLeod, C. L., et al. (2007).
Effects of FVB/NJ and C57Bl/6J
strain backgrounds on mam-
mary tumor phenotype in
inducible nitric oxide synthase
deficient mice. Transgenic Res. 16,
193–201.
Galindo, C. L., Skinner, M. A., Errami,
M., Olson, L. D., Watson, D. A.,
Li, J., et al. (2009). Transcriptional
profile of isoproterenol-induced
cardiomyopathy and compari-
son to exercise-induced cardiac
hypertrophy and human cardiac
failure. BMC Physiol. 9:23. doi:
10.1186/1472-6793-9-23
Grubb, S. C., Maddatu, T. P., Bult,
C. J., and Bogue, M. A. (2009).
Mouse phenome database. Nucleic
Acids Res. 37, D720–D730.
Jones, L. R., Suzuki, Y. J., Wang, W.,
Kobayashi, Y. M., Ramesh, V.,
Franzini-Armstrong, C., et al.
(1998). Regulation of Ca2+ signal-
ing in transgenic mouse cardiac
myocytes overexpressing calse-
questrin. J. Clin. Invest. 101,
1385–1393.
Knollmann, B. C. (2009). New roles
of calsequestrin and triadin in car-
diac muscle. J. Physiol. (Lond.) 587,
3081–3087.
Knollmann, B. C., Chopra, N., Hlaing,
T., Akin, B., Yang, T., Ettensohn, K.,
et al. (2006). Casq2 deletion causes
sarcoplasmic reticulum volume
increase, premature Ca2+ release,
and catecholaminergic polymor-
phic ventricular tachycardia. J. Clin.
Invest. 116, 2510–2520.
Kunitomo, Y., and Terentyev, D. (2011).
How to stop the fire? Control
of Ca2+-induced Ca2+ release in
cardiac muscle. J. Physiol. 589,
5899–5900.
Li, L., Desantiago, J., Chu, G.,
Kranias, E. G., and Bers, D. M.
(2000). Phosphorylation of phos-
pholamban and troponin I in
beta-adrenergic-induced accelera-
tion of cardiac relaxation. Am. J.
Physiol. Heart Circ. Physiol. 278,
H769–H779.
Liggett, S. B. (2000). Pharmacogenetics
of beta-1- and beta-2-adrenergic
receptors. Pharmacology 61,
167–173.
Linck, B., Bokník, P., Baba, H. A.,
Eschenhagen, T., Haverkamp, U.,
Jäckel, E., et al. (1998). Long-term
beta adrenoceptor-mediated alter-
ation in contractility and expression
of phospholamban and sarcoplas-
mic reticulum Ca++-ATPase in
mammalian ventricle. J. Pharmacol.
Exp. Ther. 286, 531–538.
Lum, C., Shesely, E. G., Potter, D.
L., and Beierwaltes, W. H. (2004).
Cardiovascular and renal phenotype
inmice with one or two renin genes.
Hypertension 43, 79–86.
MacLennan, D. H., and Wong,
P. T. (1971). Isolation of a
calcium-sequestering protein
from sarcoplasmic reticulum.
Proc. Natl. Acad. Sci. U.S.A. 68,
1231–1235.
Periasamy, M., and Huke, S. (2001).
SERCA pump level is a critical
determinant of Ca2+ homeostasis
and cardiac contractility. J. Mol.
Cell. Cardiol. 33, 1053–1063.
Port, J. D., and Bristow, M. R. (2001).
Altered beta-adrenergic receptor
gene regulation and signaling in
chronic heart failure. J. Mol. Cell.
Cardiol. 33, 887–905.
Roden, D. M., Johnson, J. A., Kimmel,
S. E., Krauss, R. M., Medina, M.
W., Shuldiner, A., et al. (2011).
Cardiovascular pharmacogenomics.
Circ. Res. 109, 807–820.
Sato, Y., Schmidt, A. G., Kiriazis, H.,
Hoit, B. D., and Kranias, E. G.
(2003). Compensated hypertrophy
of cardiac ventricles in aged trans-
genic FVB/N mice overexpressing
calsequestrin. Mol. Cell. Biochem.
242, 19–25.
Shah, A. P., Siedlecka, U., Gandhi, A.,
Navaratnarajah, M., Abou Al-Saud,
S., Yacoub, M. H., et al. (2010).
Genetic background affects func-
tion and intracellular calcium regu-
lation of mouse hearts. Cardiovasc.
Res. 87, 683–693.
Shan, J., Kushnir, A., Betzenhauser, M.
J., Reiken, S., Li, J., Lehnart, S.
E., et al. (2010). Phosphorylation
of the ryanodine receptor medi-
ates the cardiac fight or flight
response in mice. J. Clin. Invest. 120,
4388–4398.
Song, L., Alcalai, R., Arad, M., Wolf, C.
M., Toka, O., Conner, D. A., et al.
(2007). Calsequestrin 2 (CASQ2)
mutations increase expression
of calreticulin and ryanodine
receptors, causing catecholamin-
ergic polymorphic ventricular
tachycardia. J. Clin. Invest. 117,
1814–1823.
Terentyev, D., Kubalova, Z., Valle,
G., Nori, A., Vedamoorthyrao,
S., Terentyeva, R., et al. (2008).
Modulation of SR Ca release by
luminal Ca and calsequestrin in
cardiac myocytes: effects of CASQ2
mutations linked to sudden cardiac
death. Biophys. J. 95, 2037–2048.
Terentyev, D., Viatchenko-Karpinski,
S., Györke, I., Volpe, P., Williams,
S. C., and Györke, S. (2003).
Calsequestrin determines the func-
tional size and stability of cardiac
intracellular calcium stores: mech-
anism for hereditary arrhythmia.
Proc. Natl. Acad. Sci. U.S.A. 100,
11759–11764.
Wang, Q., Hummler, E., Nussberger, J.,
Clément, S., Gabbiani, G., Brunner,
H. R., et al. (2002). Blood pres-
sure, cardiac, and renal responses
to salt and deoxycorticosterone
acetate in mice: role of Renin
genes. J. Am. Soc. Nephrol. 13,
1509–1516.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 22 October 2012; accepted:
09 January 2013; published online: 06
March 2013.
Citation: Waters SB, Diak DM,
Zuckermann M, Goldspink PH, Leoni
L and Roman BB (2013) Genetic back-
ground influences adaptation to cardiac
hypertrophy and Ca2+ handling gene
expression. Front. Psychol. 4:11. doi:
10.3389/fphys.2013.00011
This article was submitted to Frontiers
in Genomic Physiology, a specialty of
Frontiers in Physiology.
Copyright © 2013 Waters, Diak,
Zuckermann, Goldspink, Leoni and
Roman. This is an open-access article
distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and subject to any copyright notices
concerning any third-party graphics etc.
www.frontiersin.org March 2013 | Volume 4 | Article 11 | 7
